You are here:

Oxycodone prolonged release tablets 5,10,20,40 and 80mg (OxyContin®)

Advice

Following a full submission.

Oxycodone prolonged release (OxyContin) is accepted for restricted use within NHS Scotland for the treatment of severe non-malignant pain requiring a strong opioid analgesic.

Oxycodone prolonged release is restricted to use in patients in whom controlled release morphine sulphate is ineffective or not tolerated.

Drug Details

Drug Name: Oxycodone prolonged release tablets 5,10,20,40 and 80mg (OxyContin®)
SMC Drug ID: 197/05
Manufacturer: Napp Pharmaceuticals Ltd
Indication: Severe non-malignant pain requiring a strong opioid
BNF Category:
Sub Category: 4.7 Analgesics
Submission Type: Full submission
Status: Restricted
Date Advice Published: 12 September 2005

Back